Back to search results

Ketones, SGLT2, HFrEF

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Type2diabetes · Heart Failure With Reduced Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Texas Diabetes Institute - University Health System, San Antonio, Texas, United States

    Contact: Study coordinator (Sivaram Neppala, MD) · neppalas@uthscsa.edu · 210-358-7200
    Contact: Study coordinator (Jemema Rajan, MD) · rajanj@uthscsa.edu · 210-358-7200
    Contact: Principal Investigator (Ralph DeFronzo, MD)
    Sivaram Neppala, MD (Sub-investigator)
    Jemema Rajan, MD (Sub-investigator)
Study leads

  • Ralph DeFronzo, MD

    Principal Investigator

    The University of Texas Health Science Center at San Antonio

View source on ClinicalTrials.gov(opens in a new tab)